ITL Limited is an ASX-listed company that designs and manufactures procedure packs and innovative patented medical devices, including safe blood collection devices, for global healthcare markets.
Headquartered in Canberra, the company manufactures in large facilities in Melbourne and in Malaysia. The company employs over 150 people worldwide and exports to 35 countries in Asia, Europe and America. Our funding assisted ITL in the process of stock market listing. The company has used public and internally generated funds to complete the acquisition of a number of companies that synergistically integrate with ITL's manufacturing and marketing.
ITL is a profitable company and its revenue figures are currently exceeding market expectations.
For more information please visit: www.itl-limited.com.